Elmiron MDL Leadership Established, Including G&E’s Sindhu Daniel
G&E principal Sindhu Daniel was selected to serve on the Plaintiffs Steering Committee in the Elmiron Multidistrict Litigation (MDL). The leadership team includes mostly female attorneys and is a highly diverse group. Approximately 130 Elmiron lawsuits were centralized in December 2020 before The Honorable Brian R. Martinotti in New Jersey to expedite pretrial proceedings. As the Elmiron cases, now known as MDL number 2973, move forward, more lawsuits will be filed this year by women impacted by the drug.
Elmiron is a drug manufactured by Janssen Pharmaceuticals and is the only oral drug approved by the FDA specifically for the treatment of interstitial cystitis (IC), a bladder condition that largely affects women. Prolonged use of Elmiron, however, has been linked to serious vision problems, including blurry or dimmed vision, night blindness, dark spots, and other conditions. Elmiron users are now alleging that Janssen failed to warn patients of these potentially permanent conditions.
Do You Think You Have an Elmiron Lawsuit Claim?
Contact an experienced attorney at Grant & Eisenhofer if you took Elmiron and are experiencing vision problems. Call us at (866) 575-7435 for a confidential evaluation of your potential claim.